Expertise in
11
conditions

Dr. Anand Y. Mehta

Internal Medicine
Hayward Pharmacy
27212 Calaroga Ave, 
Hayward, CA 
Expertise in
11
conditions
Hayward Pharmacy
27212 Calaroga Ave, 
Hayward, CA 

Overview

Anand Mehta is a primary care provider, practicing in Internal Medicine in Hayward, California.

Dr. Mehta is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hypothyroidism, and Osteoporosis.

He is actively involved in clinical research, participating in 6 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Hayward Pharmacy
27212 Calaroga Ave, Hayward, CA 94545

Additional Areas of Focus

Dr. Mehta has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)
An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)
Enrollment Status: Active_not_recruiting
Publish Date: April 06, 2026
Intervention Type: Drug
Study Drug: FT-4202
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 3
Safety and Efficacy of Human Regular U-500 Insulin Administered by Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Subjects With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Parallel Clinical Trial
Safety and Efficacy of Human Regular U-500 Insulin Administered by Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Subjects With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Parallel Clinical Trial
Enrollment Status: Completed
Publish Date: May 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
19
conditions
Dr. Stephen P. Luby
Internal Medicine
Expertise in
19
conditions
Dr. Stephen P. Luby
Internal Medicine

Office

473 Via Ortega # Y2, 
Stanford, CA 
 (15.5 miles away)
650-723-4129
Languages Spoken:
English

Stephen Luby is a primary care provider, practicing in Internal Medicine in Stanford, California. Dr. Luby is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Diarrhea, Parainfluenza, Typhoid Fever, and Salmonella Enterocolitis.

Expertise in
20
conditions
Dr. Eri Fukaya
Internal Medicine
Expertise in
20
conditions
Dr. Eri Fukaya
Internal Medicine

Stanford Hospital And Clinics

965 High St, 
Palo Alto, CA 
 (13.8 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eri Fukaya is a primary care provider, practicing in Internal Medicine in Palo Alto, California. Dr. Fukaya is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Varicose Veins, Venous Insufficiency, Peripheral Artery Disease, Stasis Dermatitis and Ulcers, and Thrombectomy.

Expertise in
26
conditions
Dr. Monique T. Barakat
Internal Medicine
Expertise in
26
conditions
Dr. Monique T. Barakat
Internal Medicine
Before you request

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
 (14.6 miles away)
650-723-6661
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Monique Barakat is a primary care provider, practicing in Internal Medicine in Stanford, California. Dr. Barakat is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Childhood Pancreatitis, Bile Duct Obstruction, Cholestasis, Endoscopy, and Gallbladder Removal. Dr. Barakat is currently accepting new patients.

Frequently Asked Questions about Dr. Anand Y. Mehta

How do I make an appointment with Dr. Anand Y. Mehta?

You can book an appointment with Dr. Anand Y. Mehta by calling their office at 510-293-5668. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Anand Y. Mehta a top-rated expert for Type 2 Diabetes (T2D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anand Y. Mehta is classified as an Advanced expert for Type 2 Diabetes (T2D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Anand Y. Mehta specialize in?

While Dr. Anand Y. Mehta is a Internal Medicine, they have specific expertise in Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Hypothyroidism. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Anand Y. Mehta accept my insurance?

Dr. Anand Y. Mehta accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 510-293-5668 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mehta's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 91 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile